C12N 2710/00071
Demonstrated in vivo effect
C12N2710/00071 (Demonstrated in vivo effect) appears on 2 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 9
- Assignees
- 3
- Inventors
- 15
- Latest grant
- 28 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Mutant nudivirus insect control27 Nov 2025US 2025/0361493 A1University of Kentucky Research Foundation
- Compositions and Methods for Gene Delivery to the Airways and/or Lungs20 Feb 2025US 2025/0059565 A1Krystal Biotech, Inc.
- Mutant nudivirus insect control25 May 2023US 2023/0159900 A1University of Kentucky Research Foundation
- Recombinant Ranavirus, Methods of Production, and Its Use As A Mammalian Expression System15 Jul 2021US 2021/0214750 A1
- Compositions and methods for gene delivery to the airways and/or lungs24 Jun 2021US 2021/0189427 A1Krystal Biotech, Inc.
Most cited
By later US patents